- Report
- October 2024
- 196 Pages
Global
From €3360EUR$3,545USD£2,807GBP
€3733EUR$3,939USD£3,119GBP
- Report
- April 2025
- 50 Pages
Global
From €2512EUR$2,650USD£2,098GBP
Lorcaserin is a prescription anti-obesity drug used to treat overweight and obese adults. It works by activating serotonin receptors in the brain, which helps to reduce appetite and promote feelings of fullness. It is typically prescribed in combination with a reduced-calorie diet and increased physical activity. Common side effects include nausea, headache, dizziness, and fatigue.
The lorcaserin market is a rapidly growing segment of the anti-obesity drug market. It is expected to benefit from the increasing prevalence of obesity and the growing awareness of the health risks associated with it. Additionally, the increasing availability of generic versions of lorcaserin is expected to drive market growth.
Some of the major companies in the lorcaserin market include Arena Pharmaceuticals, Eisai Co., Ltd., Orexigen Therapeutics, Inc., and Vivus, Inc. Show Less Read more